nach oben

Erschienen in:

Open Access 11.10.2023 | Original Communication

Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis

verfasst von: Veronica Ravano, Gian Franco Piredda, Jan Krasensky, Michaela Andelova, Tomas Uher, Barbora Srpova, Eva Kubala Havrdova, Karolina Vodehnalova, Dana Horakova, Petra Nytrova, Jonathan A. Disselhorst, Tom Hilbert, Bénédicte Maréchal, Jean-Philippe Thiran, Tobias Kober, Jonas Richiardi, Manuela Vaneckova

Erschienen in: Journal of Neurology | Ausgabe 2/2024

Abstract

Objectives

Microstructural characterization of patients with multiple sclerosis (MS) has been shown to correlate better with disability compared to conventional radiological biomarkers. Quantitative MRI provides effective means to characterize microstructural brain tissue changes both in lesions and normal-appearing brain tissue. However, the impact of the location of microstructural alterations in terms of neuronal pathways has not been thoroughly explored so far. Here, we study the extent and the location of tissue changes probed using quantitative MRI along white matter (WM) tracts extracted from a connectivity atlas.

Methods

We quantified voxel-wise T1 tissue alterations compared to normative values in a cohort of 99 MS patients. For each WM tract, we extracted metrics reflecting tissue alterations both in lesions and normal-appearing WM and correlated these with cross-sectional disability and disability evolution after 2 years.

Results

In early MS patients, T1 alterations in normal-appearing WM correlated better with disability evolution compared to cross-sectional disability. Further, the presence of lesions in supratentorial tracts was more strongly associated with cross-sectional disability, while microstructural alterations in infratentorial pathways yielded higher correlations with disability evolution. In progressive patients, all major WM pathways contributed similarly to explaining disability, and correlations with disability evolution were generally poor.

Conclusions

We showed that microstructural changes evaluated in specific WM pathways contribute to explaining future disability in early MS, hence highlighting the potential of tract-wise analyses in monitoring disease progression. Further, the proposed technique allows to estimate WM tract-specific microstructural characteristics in clinically compatible acquisition times, without the need for advanced diffusion imaging.

Supplementary file1 (DOCX 3501 KB)

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s00415-023-12023-3.

Introduction

In recent years, the development of quantitative magnetic resonance imaging (qMRI) techniques with clinically feasible acquisition times has enabled the characterization of microstructural changes in brain tissue in clinical research settings. In multiple sclerosis (MS), qMRI was shown to provide valuable information, especially with regard to the iron and myelin content [1, 2], both within lesions and normal-appearing tissue [3]. In this context, T1 relaxation time is an effective imaging biomarker known to be associated with demyelination, iron accumulation and axonal loss [4].

Previous studies showed the clinical value of T1 mapping in MS. In particular, lesions with longer T1 values (so-called black holes) were shown to be better associated with disability compared to total lesion volume (TLV) [5]. Further, longitudinal microstructural changes in black holes was shown to be correlated with disability evolution [6]. Likewise, T1 relaxation values were reported to improve disability prediction when measured in normal-appearing brain tissue [7‐9].

Not only the extent of the microstructural damage, but also the location of brain damage is known to play an important role in explaining disability [10]. Microstructural alterations in white matter (WM) tracts are of particular interest as different white matter pathways are known to be responsible for different brain functions, hence enabling lesion-to-symptom mapping [11, 12]. In this context, estimating damage based on structural connectivity, which takes into account the location of a lesion, has been shown to improve the correlation with Expanded Disability Status Scale (EDSS) [13‐16].

In addition to their potential clinical relevance, white matter tract-based analyses are required to study pathophysiological mechanisms such as Wallerian degeneration [17], previously shown to play a role in MS [18‐20]. This retrograde degeneration suggests that with time, the presence of a demyelinating focal lesion on a white matter tract can induce microstructural changes on more distal portions of the tract. Along these lines, previous work showed that the presence of lesions in the pons was inducing microstructural diffusion changes not only at the lesion site but also along the entire affected tract [16]. Furthermore, evaluating microstructural properties in a selection of white matter tracts using T1 relaxometry, was shown to result in significant correlations with specific functional scores and EDSS [21].

To date, there has been little research into the microstructural properties of specific white matter pathways due to its limited feasibility in a clinical setting. In fact, the delineation of white matter tracts relies on high-quality diffusion imaging data, typically characterized by long acquisition times, and model-based tractography algorithms that often result in limited inter-patient comparability.

In this work, we evaluated the distribution and extent of abnormal T1 relaxation times along white matter tracts extracted from a connectivity atlas. Deviations in T1 values were calculated with respect to a normative atlas considering age and sex. The clinical value of the proposed technique was assessed by correlation with EDSS and disability progression over 2 years in two distinct MS cohorts (early MS and progressive MS).

Methods

Participants

The cohort included 92 healthy subjects (age 37.3 ± 10.6 years, 63% female), 47 patients with first symptoms suggestive of MS (age 31.8 ± 8.0 years, 75% female), and 52 patients with progressive MS (including 7 primary and 45 secondary progressive MS, age 49.9 ± 7.2 years, 65% female). Detailed demographics and clinical scores are reported in Table 1.

Table 1

Demographics and disease characteristics of healthy individuals and MS cohorts

Parameter	Healthy cohort	Early MS	Progressive MS	W (p-value)
N (% female)	92 (63%)	47 (75%)	52 (65%)	–
Age (years)	37.3 ± 10.6	32.4 ± 8.0	49.8 ± 7.3	2255 (5.9 × 10^–14)
Disease duration	–	6.3 ± 5.4 months	19.45 ± 7.8 years	2346 (< 10^–16)
EDSS₀	–	1.87 ± 0.77	5.20 ± 0.89	2387 (< 10^–16)
ΔEDSS	–	0.01 ± 0.54	0.24 ± 0.55	1468 (0.037)
Δt [months]	–	24.7 ± 1.3	25.0 ± 3.7	1488 (0.04)
TLV [mL]	–	6.7 ± 8.7	14.3 ± 15.3	1721 (2 × 10^–4)
TLC [# of lesions]	–	22.2 ± 23.6	28.1 ± 15.9	1615 (0.003)

The results of the Wilcoxon rank-sum test comparison between MS groups are reported in the last column

EDSS Expanded Disease Disability Scale; ΔEDSS EDSS change in 2 years; Δt time elapsed between clinical evaluations; TLV total lesion volume; TLC total lesion count

Patients and healthy subjects underwent MR examinations at 3T (MAGNETOM Skyra, Siemens Healthcare, Erlangen, Germany) using a standard 20-channel head coil. A 3D magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE) sequence was used for T1 mapping [22, 23] in addition to the standard clinical imaging used for lesion detection, consisting of a 3D magnetization-prepared rapid gradient echo (MP-RAGE) and a 3D fluid-attenuated inversion recovery (FLAIR). Detailed sequence parameters are reported in Table 2.

Table 2

Relevant MRI acquisition parameters

Parameter	3D MP-RAGE	3D FLAIR	3D MP2RAGE
Parameter	3D MP-RAGE	3D FLAIR	HC and early MS	Progressive MS
Resolution [mm³]	1.0 × 1.0 × 1.0	1.0 × 1.0 × 1.0	1.0 × 1.0 × 1.2	1.0 × 1.0 × 1.0
Field of view [mm³]	256 × 256 × 176	256 × 256 × 176	256 × 256 × 212	256 × 256 × 224
Undersampling	GRAPPA × 2	GRAPPA × 3	GRAPPA × 3	CS × 4
TA [min]	5:30	3:17	8:22	4:35
TI₁/TI₂ [ms]	900/–	1800/–	700/2500
TE [ms]	–	397	–
Flip angles [°]	9	–	4/5
TR [s]	2.3	5	5
Bandwidth [Hz/Px]	240	781	240

MP-RAGE magnetization-prepared rapid gradient echo; FLAIR fluid-attenuated inversion recovery; MP2RAGE magnetization-prepared 2 rapid gradient echo; TA acquisition time; TI inversion time; TE echo time; TR repetition time; CS compressed sensing

Patients were scored using EDSS [24]. The neurological examinations were conducted shortly after (0.9 ± 1.0 months), and 2 years after (24.2 ± 3.0 months) the MR examination. Clinical examinations were always conducted outside any clinical relapse and at least 30 days after the administration of corticosteroids.

In the early cohort, the majority patients received first-line treatments (43/47), while four did not receive any treatment, and eleven patients received second-line treatments after 2 years. In the progressive cohort, most patients were treated with second-line drugs at the time of the first clinical examination (30/52). The precise breakdown of treatment status within both groups is reported in Supplementary Table 1.

To ensure T1 values were consistent between both undersampling techniques and in addition to the analyses conducted in [23], we compared T1 maps and z-score maps in a patient with progressive MS, who was examined with both GRAPPAx3 and CSx4 MP2RAGE.

Preprocessing

A lesion segmentation research application [25, 26] that performs voxel-wise lesion detection, followed by partial volume estimation was used to automatically segment lesions on FLAIR and MP-RAGE images. A threshold was applied to the resulting lesion concentration maps to obtain binary lesion masks as described previously [25]. For each patient, an affine spatial transformation was computed between the MP-RAGE and the MP2RAGE space and applied to the binary lesion mask using Elastix [27]. Total lesion volume (TLV) and count (TLC) were extracted for each patient.

Automated brain segmentation and skull-stripping were performed on the MP2RAGE contrast using the MorphoBox research application [28].

T1 normative atlas

The calculation of the T1 abnormalities follows the method of Piredda et al. [29] where it is described in more detail. In short, 20 skull-stripped MP2RAGE datasets were randomly selected from the healthy subjects cohort and the skull-striped uniform (UNI) MP2RAGE images were co-registered to build a study-specific template (SST) [30]. Then, spatial transformations between the skull-stripped UNI images data of all subjects in the healthy cohort and the SST were computed and applied to the associated T1 maps. Finally, normative T1 values were established using a linear voxel-wise model of inter-subject variability in T1 values, while considering age (centered at the average age of the healthy cohort) and sex as covariates:

$${\varvec{E}}\left\{T1\right\}= {\beta }_{0}+{\beta }_{\mathrm{sex}}*\mathrm{sex}+{\beta }_{\mathrm{age}}*\mathrm{age}+{\beta }_{{\mathrm{age}}^{2}}*{\mathrm{age}}^{2},$$

with ${\beta }_{0}$ being the model intercept, and sex a categorical variable equal to 1 if the subject is male or 0 if female as detailed in Piredda et al. [29].

Atlas-based white matter tract maps

Voxel-wise tract density maps, representing the number of streamlines passing through each voxel, were extracted for white matter tracts defined in a tractography atlas [31], using DSI Studio (Fig. 1A, B). Tracts that were defined in both hemispheres were merged into a single tract by summing the density maps voxel-wise, resulting in 37 white matter tracts. A non-linear spatial registration with trilinear B-spline interpolation between the MNI space (where the tractography atlas was originally defined) and the SST was computed using Elastix [27] and applied to all tract density maps. Finally, each map was normalized by its maximum value and binarized using a threshold at 5% to discard voxels with low tract density.

Extraction of tract-specific z-scores

For each patient, the non-linear spatial registration between the skull-stripped UNI image and the SST was computed with Elastix [27] and applied to the associated T1 map. Then, voxel-wise deviations (measured as z-scores) from the established T1 normative atlas were computed (Fig. 1C, D), yielding a map which shows how many standard deviations the T1 in each voxel is away from the mean, as described in Piredda et al. [29]. To discard cases with insufficient registration quality, typically caused by the presence of brain atrophy, we computed the mutual information from the joint histogram of the registered anatomical UNI image and the SST. Then, a threshold was set to the fifth percentile of the mutual information estimated on the whole MS cohort, and the so-detected datasets were visually inspected.

White matter tract-specific analysis was performed by superimposing the white matter tract density images and the T1 z-score maps of individual patients in the SST space (Fig. 1E). In each tract, we extracted two imaging biomarkers: the average absolute z-score value (${\mu }_{|z|}$), representing the magnitude of deviation from the norm, and the number of voxels with an absolute z-score larger than 2 (${V}_{\left|z\right|>2}$), representing the spatial extent of the deviation from the norm, both in NAWM and lesions. For comparison, the tract-specific lesion volume (LV) was also computed by estimating the volume of lesions on each tract from the registered lesion mask.

Statistical analysis

All statistical analyses were performed using RStudio v1.1.456 [32].

Spearman correlations were computed between the tract-specific metrics (LV, ${V}_{\left|z\right|>2}^{\mathrm{NAWM}}$, ${V}_{\left|z\right|>2}^{\mathrm{lesions}}$, ${\mu }_{|z|}^{\mathrm{NAWM}},$ and ${\mu }_{|z|}^{\mathrm{lesions}}$) and disability in both MS cohorts and compared to radiological metrics reflecting lesion load, namely the TLV and TLC. Both cross-sectional EDSS (EDSS₀) and EDSS change after 2 years (ΔEDSS) were considered for this analysis.

Permutation tests (N = 5000) were used to statistically compare the magnitude of tract-specific correlations, each time by randomizing the order of the EDSS scores across patients. The obtained p-values were corrected for multiple comparisons across white matter tracts by using the Benjamini–Hochberg method.

First, to test which imaging biomarker obtained the highest clinical correlation, we compared correlation amplitudes from the tract-specific average absolute z-score (${\mu }_{|z|}$) (“magnitude of deviation from the norm") with correlations of the volume of absolute z-scores exceeding a threshold of two (${V}_{\left|z\right|>2}$) (“spatial extent of deviation from the norm”), hence defining the following null hypotheses:

$${H}_{0}:|c\left({\mu }_{\left|z\right|}^{\mathrm{NAWM}}, {\mathrm{EDSS}}_{0}\right)|-|c\left({V}_{\left|z\right|>2}^{\mathrm{NAWM}}, {\mathrm{EDSS}}_{0}\right)|=0,$$

$${H}_{0}:|c\left({\mu }_{\left|z\right|}^{\mathrm{lesions}}, {\mathrm{EDSS}}_{0}\right)|-|c\left({V}_{\left|z\right|>2}^{\mathrm{lesions}}, {\mathrm{EDSS}}_{0}\right)|=0,$$

where c(X, EDSS₀) represents the correlation between the imaging biomarker X and the cross-sectional EDSS.

Second, we assumed that due to their ability to reflect the extent and severity of microstructural tissue damage, imaging biomarkers reflecting T1 abnormalities yield stronger correlations with EDSS, compared to tract-specific lesion load. Hence, we compared correlation amplitudes obtained from tract-specific z-score metrics to lesion load per tract with cross-sectional EDSS using one-sided permutation tests under these null hypotheses:

$${H}_{0}:|c\left({\mu }_{\left|z\right|}^{\mathrm{NAWM}}, {\mathrm{EDSS}}_{0}\right)|-|c\left(\mathrm{LV},\mathrm{ EDS}{\mathrm{S}}_{0}\right)|\le 0,$$

$${H}_{0}:|c\left({\mu }_{\left|z\right|}^{\mathrm{lesions}}, {\mathrm{EDSS}}_{0}\right)|-|c\left(\mathrm{LV}, {\mathrm{EDSS}}_{0}\right)|\le 0.$$

Third, to test whether the imaging biomarkers better reflected current or future EDSS scores (progression), correlations between tract-specific metrics and cross-sectional EDSS were also compared to EDSS change (ΔEDSS) using two-sided permutation tests, with the following null hypotheses:

$${H}_{0}:|c\left({\mu }_{\left|z\right|}^{\mathrm{NAWM}}, {\mathrm{EDSS}}_{0}\right)|-|c\left({\mu }_{\left|z\right|}^{\mathrm{NAWM}}, \Delta \mathrm{EDSS}\right)|=0,$$

$${H}_{0}:|c\left({\mu }_{\left|z\right|}^{\mathrm{lesions}}, {\mathrm{EDSS}}_{0}\right)|-|c\left({\mu }_{\left|z\right|}^{\mathrm{lesions}}, \Delta \mathrm{EDSS}\right)|=0,$$

$${H}_{0}:|c\left(\mathrm{LV},\mathrm{ EDS}{\mathrm{S}}_{0}\right)|-|c\left(\mathrm{LV}, \Delta \mathrm{EDSS}\right)|=0.$$

Results

When measured in the same patient, T1 values derived from GRAPPAx3 and CSx4 MP2RAGE sequences yielded comparable results, in accordance with the previous reports [23] (see Supplementary Fig. 1).

Overall, seven patients with progressive MS were discarded from the analysis due to insufficient registration quality, caused by the presence of severe atrophy. Supplementary Fig. 2 provides examples of good and bad registration quality.

T1 z-score maps estimated in WM tracts are shown in Fig. 2 for two representative patients with early MS in six example WM tracts. The two patients are characterized by similar TLV (11.8 and 10.8 mL), but different EDSS evolution: while the first patient’s EDSS increased by 1 over 2 years, the second patient remained stable over the same period. When looking at the z-score maps, the first patient was characterized by larger T1 deviations in most WM tracts compared to the second patient, particularly in NAWM.

General observations

Tract-specific average absolute z-scores (${\mu }_{|z|}$) and volumes of z-scores exceeding a threshold of 2 (${V}_{\left|z\right|>2}$) resulted in comparable correlations with EDSS when estimated both in lesions and NAWM. The difference in correlation when estimating ${\mu }_{|z|}$ compared to ${V}_{\left|z\right|>2}$ did not result in significant differences after correction for multiple comparisons. Hence, we only report the results of correlation comparisons in terms of ${\mu }_{|z|}$.

Figure 3 shows the Spearman correlations computed between tract-specific metrics (lesion load and T1 z-scores in NAWM) and both EDSS measures (EDSS₀ and ΔEDSS) in both cohorts, together with abbreviations for all tracts mentioned hereafter. The correlations obtained from metrics reflecting T1 abnormalities specifically in lesioned tissue are reported in Supplementary Fig. 3. The posterior commissure (PC) and dorsal longitudinal fasciculus (DLF) were removed from statistical analyses when considering lesion-related metrics due to an insufficient number of patients presenting lesions in these tracts.

In early MS, estimating tract-specific lesion load yielded to higher correlations with EDSS₀ compared to TLV (ρ = 0.20, p = 0.16) and TLC (ρ = 0.16, p = 0.28) for 17/37 WM tracts, whereas it did not yield stronger correlations in the progressive cohort TLV (ρ = 0.20, p = 0.19), TLC (ρ = 0.25, p = 0.09) for most tracts (35/37).

The estimation of T1 z-scores in NAWM significantly improved the correlation with cross-sectional EDSS compared to tract-specific lesion load for two tracts in the early cohort: the frontal aslant tract (FAT) and the superior longitudinal fasciculus (SLF); and for five tracts in the progressive cohort: the middle longitudinal fasciculus (MdLF), the inferior cerebellar peduncle (ICP), the optic radiation (OR), the temporo-pontine tract (TPT), and the rubrospinal tract (RST), as reported in Supplementary Tables 2 and 3. The estimation of T1 z-scores inside lesions yielded a substantial, yet non-significant, increase in correlation to EDSS₀ compared to tract-specific lesion load for some supratentorial tracts in the progressive cohort, whereas no notable difference could be observed for the early cohort.

Early MS cohort

Table 3 reports the significant results obtained from the correlation comparisons between ΔEDSS and EDSS₀ in early MS patients. Overall, a drop in correlations was observed for supratentorial tract-specific lesion load when considering ΔEDSS compared to EDSS₀. This difference was significant for nine association or projection pathways (highlighted by yellow stars in Fig. 3): the acoustic radiation (AR), the occipito-pontine tract (OPT), the optic radiation (OR), the parieto-pontine tract (PPT), the temporo-pontine tract (TPT), the extreme capsule (EMC), the inferior fronto-occipital fasciculus (IFOF), the inferior longitudinal fasciculus (ILF) and the U fibers (U), as well for one brain stem tract: the lateral lemniscus (LL). On the other hand, higher correlations were observed for four infratentorial tracts (highlighted with red stars in Fig. 3): the superior cerebellar peduncle (SCP), the cerebellum (CB), the inferior cerebellar peduncle (ICP) and the medial longitudinal fasciculus (MLF). The five tracts that yielded to the highest correlations to EDSS₀ were mostly projection pathways [AR (ρ = 0.39, p = 0.006), TPT (ρ = 0.37, p = 0.011), EMC (ρ = 0.31, p = 0.03), FPT (ρ = 0.35, p = 0.015), C (ρ = 0.30, p = 0.04)], whilst those with the strongest correlations to ΔEDSS were infratentorial tracts [ML (ρ = 0.37, p = 0.01), STT (ρ = 0.37, p = 0.011), CTT (ρ = 0.35, p = 0.02), RST (ρ = 0.35, p = 0.02), SCP (ρ = 0.32, p = 0.03)].

Table 3

Significant results obtained from correlation comparisons between EDSS₀ and ΔEDSS in the early MS cohort

	$c\left(\mathrm{LV},\mathrm{ EDS}{\mathrm{S}}_{0}\right)$	$c\left(\mathrm{LV}, \Delta \mathrm{EDSS}\right)$	${p}_{\mathrm{adj}}$		$c\left( {\upmu }_{\left\|\mathrm{z}\right\|}^{\mathrm{NAWM}},{\mathrm{EDSS}}_{0}\right)$	$c\left({\upmu }_{\left\|\mathrm{z}\right\|}^{\mathrm{NAWM}},\Delta \mathrm{EDSS},\right)$	${p}_{\mathrm{adj}}$
MLF	−0.02	0.30	0.003	IFOF	0.006	0.36	0.018
CB	0.07	0.26	0.003	ILF	0.04	0.29	0.039
ICP	0.01	0.26	0.004	MLF	0.03	0.22	0.039
SCP	0.07	0.32	0.046	ICP	−0.02	0.28	0.039
AR	0.39	−0.15	0.015	AC	−0.01	0.23	0.041
OPT	0.26	−0.06	0.018	SCP	0.01	0.23	0.047
OR	0.30	−0.02	0.003	SLF	0.37	0.16	0.039
TPT	0.37	−0.01	0.003	LL	0.32	0.1	0.036
PPT	0.19	0.04	0.035
EMC	0.31	−0.08	0.006
IFOF	0.21	0.03	0.027
ILF	0.23	−0.05	0.027
U	0.28	0.008	0.003
LL	0.29	0.14	0.014

For each tract, the highest correlation is highlighted in bold

In contrast, a substantial increase was observed for most tracts when correlating NAWM z-scores metrics with ΔEDSS compared to cross-sectional EDSS₀. However, after correction for multiple comparisons, only six tracts exhibited a significant increase: the IFOF, the ILF, the MLF, the ICP, the SCP and the anterior commissure (AC). On the other hand, the lateral lemniscus (LL) and the superior longitudinal fasciculus (SLF) presented a significantly stronger correlation with EDSS₀ compared to ΔEDSS. In contrast to tract-specific lesion load, the lowest correlations between ${\upmu }_{\left|\mathrm{z}\right|}^{\mathrm{NAWM}}$ and ΔEDSS were found in the brainstem and commissural tracts (PC (ρ = −0.06), LL (ρ = 0.09), STT (ρ = 0.14), C (ρ = 0.15), SLF (ρ = 0.16), all with p > 0.05), whilst cerebellar and projection pathways yielded comparatively high correlations.

When considering T1 z-score metrics estimated in lesions (reported in Supplementary Fig. 3 and Supplementary Table 2), the correlations were significantly higher for ∆EDSS compared to EDSS₀ for the MLF, the SCP and the ICP. The strongest correlations to ∆EDSS were again observed for infratentorial tracts [SCP (ρ = 0.40, p = 0.0058), ML (ρ = 0.36, p = 0.013), RST (ρ = 0.35, p = 0.01), STT (ρ = 0.35, p = 0.01), CTT (ρ = 0.35, p = 0.02)].

Progressive MS cohort

In the progressive cohort, the lesion load in tracts did not result in significantly different correlations when associated to ∆EDSS compared to EDSS₀. Compared to the early MS cohort, the correlations to EDSS₀ were smaller (ρ < 0.3) and none was statistically significant. Additionally, correlation values differed greatly between white matter tracts belonging to the same pathways and no specific spatial pattern could be identified.

When considering ∆EDSS, a substantial drop in correlation was observed for all tracts both in terms of tract-specific lesion load and NAWM z-scores compared to EDSS₀. This resulted in extremely poor and often negative correlations and often negative correlations.

Finally, when considering z-scores metrics extracted in lesions (reported in Supplementary Fig. 3 and Supplementary Table 2), the correlations were overall decreased for ∆EDSS compared to EDSS₀. However, these differences were never significant. Again, similar to what was observed for tract-specific lesion load, the infratentorial tracts, and particularly brainstem tracts, were among the most weakly correlated both with EDSS₀ (SCP = −0.01, FAT = 0.04, ICP = −0.05, RST = −0.05, MCP = 0.07, all with p > 0.05) and ∆EDSS (U = 0.002, ICP = 0.006, CB = −0.02, LL = −0.02, FPT = −0.02, all with p > 0.05).

Discussion

We proposed a technique to estimate microstructural properties of brain tissue along WM tracts which were extracted from a connectivity atlas, i.e., without the need of additional diffusion imaging. A normative T1 atlas was used to extract patient-specific voxel-wise deviations while accounting for sex and age, as both are known to impact T1 values in the brain [29, 33].

Overall, our results suggest that the spatial distribution of lesions and microstructural alterations in WM tracts can improve the correlation with both cross-sectional disability and its evolution over 2 years compared to total lesion volume and count. In contrast to the early MS patients, the differences in correlation between tract-specific metrics and EDSS₀ and ΔEDSS, respectively, were never significant in the progressive cohort. This distinction observed between the two disease stages can probably be explained by a higher disease activity in the earlier stages of the disease, whilst a more stationary phase is reached with longer disease durations. Additionally, the EDSS is an ordinal scale that is known to reflect disability in a non-linear way: depending on the disease stage, the same increase in EDSS is not reflected by the same severity of disability evolution. Hence, considering ΔEDSS as a measure of disease evolution bears limitations in terms of interpretability and comparability between MS groups. Furthermore, different therapeutic strategies might influence differently disability evolution: the use of more aggressive therapies in the progressive MS cohort is likely to have an impact on ΔEDSS and might, therefore, contribute to explaining the lower correlations.

Of particular interest is that in patients with early-stage MS, the contribution to the characterization of current and future disability appears to be very different depending on the WM pathway that is considered as different patterns were observed for association and projection pathways compared to infratentorial tracts (brainstem and cerebellar bundles).

The presence of lesions in infratentorial tracts correlated more strongly with disability change than cross-sectional EDSS, while an opposite trend was observed for many projection and association pathways. These findings suggest that, when estimated in supratentorial pathways, tract-specific lesion load is mainly contributing to explaining the current disability of the patient, whilst the presence of lesions in infratentorial tracts has a larger impact on the future evolution of the disease course. These results are in concordance with previous work showing the predictive power of infratentorial lesions to longitudinal disability [34]. One possible explanation is Wallerian degeneration [17], that has been widely studied in the context of MS [19, 20, 35]. Such a retrograde alteration of axonal pathways might have a bigger impact on brain function when infratentorial tracts are affected by lesions, since damage occurring at a more proximal level of the axonal pathway is more likely to involve a larger portion of fibers than damage in distal sections. Another hypothesis is that brain plasticity could be more effectively compensating alterations of high-level brain functions, typically modulated by association and projection pathways (e.g., motor, and sensory systems), than autonomic functions that are regulated in infratentorial regions (e.g., urination, awareness).

The evaluation of T1 alterations in tract-specific NAWM resulted in stronger correlations with disability change for some supratentorial and cerebellar pathways, compared to cross-sectional EDSS, except for brainstem tracts. These findings suggest that the subtle tissue alterations found in the NAWM are more predictive of future disease activity than to lesion load. Similar observations were made evaluating periventricular gradients of T1 alterations in the NAWM compared to regional lesion volume [9].

When comparing the correlations obtained from tract-specific z-score metrics in lesions, despite being comparatively high, the differences were rarely significant. One probable explanation is that only few patients exhibit lesions in certain tracts, therefore driving the correlation (see Supplementary Fig. 4). However, when performing permutations, these correlations do not hold and the correlation difference drops.

The limitations of the proposed technique include the need for a non-linear registration between the native patient space and the SST that could result in false-positive z-scores notably at the boundaries of the white matter, as also reported originally by Piredda et al. [29]. This is of particular concern when considering patients with severe atrophy, hence limiting the applicability of the developed method in progressive patients. Further, the goodness of fit of the regression model used to estimate normative T1 values depends on the size and the age span of the healthy cohort. Therefore, estimating z-score values in patients whose age is outside the range spanned by the healthy cohort could result in loss of precision. By using a tractography atlas to model structural connectivity, our method does not account for individual anatomical differences in white matter tracts. Such differences can result from both normal aging process and adaptative mechanisms that occur in the presence of pathology, such as Wallerian degeneration.

By considering the absolute values of z-score maps, the same weight was given to positive and negative deviations in T1 values. While the vast majority of significant T1 z-scores were positive, sparsely distributed negative z-scores were also sporadically observed. Future work will focus in investigating the presence and possible cause of such T1 decrease, also in combination with other relaxometry atlases. Further, the spatial distribution of T1 abnormalities along white matter tracts could also be investigated as a new measure of connectivity damage.

In conclusion, estimating T1 abnormalities both in lesions and NAWM along white matter tracts improves the correlation with current and future disability in MS in patients at an early disease stage. Furthermore, our approach allows to estimate microstructural changes in strategic brain locations in a clinical setting without requiring lengthy advanced diffusion imaging, hence within clinically compatible acquisition and processing times. Our results suggest that, while the presence of infratentorial lesions correlates strongly with cross-sectional disability, the evaluation of T1 alterations in the NAWM is more predictive of future disability change in 2 years in early MS patients. Hence, our method provides promising additional prognostic information to the presence of conventionally accepted negative prognostic markers (e.g., infratentorial and intramedullary), that could contribute to identifying early MS patients with higher risk of progression in a context of therapy planning.

Declarations

Conflicts of interest

The authors of this manuscript declare relationships with the following companies: V. Ravano, J-P. Thiran and J. Richiardi have no financial or proprietary interests in any material discussed in this article. G.F. Piredda, J.A. Disselhorst, T. Hilbert, B. Maréchal and T. Kober are employed by Siemens Healthineers International AG, Switzerland. M. Vaneckova received compensation for speaker honoraria, travel and consultant fees from Biogen, Sanofi Genzyme, Novartis, Roche and Teva, as well as support for research activities from Biogen. J. Krasensky received financial support for research activities from Biogen Idec. M. Andelova received financial support for conference travel from Novartis, Genzyme, Merck Serono, Biogen Idec and Roche. T. Uher received financial support for conference travel from Biogen Idec, Novartis, Sanofi, Roche and Merck Serono and speaker honoraria from Biogen Idec, Novartis and Roche as well as support for research activities from Biogen Idec and Sanofi. B. Srpova received compensation for traveling and conference fees from Novartis, Sanofi Genzyme, Biogen Idec, Roche and Merck as well as support for research activities from Biogen Idec. E.K. Havrdova received speaker honoraria and consultant fees from Biogen Idec, Merck Serono, Novartis, Genzyme and Teva, as well as support for research activities from Biogen Idec and Merck Serono. K. Vodehnalova received compensation for traveling, conference fees and consulting fees from Merck, Teva, Sanofi Genzyme, Biogen Idec, Novartis, Roche. D. Horakova received compensation for travel, speaker honoraria, and consultant fees from Biogen Idec, Novartis, Merck, Bayer, Sanofi Genzyme, Roche and Teva, as well as support for research activities from Biogen Idec. She was also supported by the Czech Ministry of Education project Progress Q27/LF1. P. Nytrova received speaker honoraria and consultant fees from Biogen, Novartis, Merck, Roche, and financial support for research activities from Roche and Merck.

Ethical approval

The study was conducted according to the Declaration of Helsinki and The Ethics Committee of the General Teaching Hospital in Prague provided approval for the examination of both MS patients and for healthy individuals. All participants gave their written informed consent.

Written informed consent was obtained from all patients in this study.

Not applicable as no individual details are reported.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Jetzt testen ¹

Neuer Inhalt

Jetzt informieren

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Jetzt testen ²

e.Med Neurologie

Kombi-Abonnement

Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.

Jetzt testen ³

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 3501 KB)

Tranfa M, Pontillo G, Petracca M et al (2022) Quantitative MRI in multiple sclerosis: from theory to application. Am J Neuroradiol 43(12):1688–1695. https://doi.org/10.3174/ajnr.A7536CrossRefPubMed

Granziera C, Wuerfel J, Barkhof F et al (2021) Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain 144:1296–1311. https://doi.org/10.1093/brain/awab029CrossRefPubMedPubMedCentral

Jonkman LE, Soriano AL, Amor S et al (2015) Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study. J Neurol 262:1074–1080. https://doi.org/10.1007/s00415-015-7689-4CrossRefPubMedPubMedCentral

Mottershead JP, Schmierer K, Clemence M et al (2003) High field MRI correlates of myelin content and axonal density in multiple sclerosis: a post-mortem study of the spinal cord. J Neurol 250:1293–1301. https://doi.org/10.1007/s00415-003-0192-3CrossRefPubMed

Thaler C, Faizy T, Sedlacik J et al (2015) T1-thresholds in black holes increase clinical–radiological correlation in multiple sclerosis patients. PLoS ONE 10:1–13. https://doi.org/10.1371/journal.pone.0144693CrossRef

Thaler C, Faizy TD, Sedlacik J et al (2017) T1 recovery is predominantly found in black holes and is associated with clinical improvement in patients with multiple sclerosis. Am J Neuroradiol 38:264–269. https://doi.org/10.3174/ajnr.A5004CrossRefPubMedPubMedCentral

Vrenken H, Geurts JJG, Knol DL et al (2006) Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 240:811–820. https://doi.org/10.1148/radiol.2403050569CrossRefPubMed

Manfredonia F, Ciccarelli O, Khaleeli Z et al (2007) Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis. Arch Neurol 64:411–415. https://doi.org/10.1001/archneur.64.3.411CrossRefPubMed

Vaneckova M, Piredda GF, Andelova M et al (2022) Periventricular gradient of T1 tissue alterations in multiple sclerosis. Neuroimage Clin 34:1–10. https://doi.org/10.1016/j.nicl.2022.103009CrossRef

10.

Vellinga MM, Geurts JJG, Rostrup E et al (2009) Clinical correlations of brain lesion distribution in multiple sclerosis. J Magn Reson Imaging 29:768–773. https://doi.org/10.1002/jmri.21679CrossRefPubMed

11.

Foulon C, Cerliani L, Kinkingnéhun S et al (2018) Advanced lesion symptom mapping analyses and implementation as BCBtoolkit. Gigascience 7:1–17. https://doi.org/10.1093/gigascience/giy004CrossRefPubMed

12.

Fox M (2018) Mapping symptoms to brain networks with the human connectome. N Engl J Med 379:2237–2245. https://doi.org/10.1056/NEJMra1706158CrossRefPubMed

13.

Rise HH, Brune S, Chien C et al (2022) Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: a longitudinal multicenter study. Neuroimage (Amst). https://doi.org/10.1016/j.nicl.2022.103099CrossRef

14.

Ravano V, Andelova M, Fartaria MJ et al (2021) Validating atlas-based lesion disconnectomics in multiple sclerosis: a retrospective multi-centric study. Neuroimage Clin 32:102817. https://doi.org/10.1016/j.nicl.2021.102817CrossRefPubMedPubMedCentral

15.

Hulst HE, Steenwijk MD, Versteeg A et al (2013) Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology 80:1025–1032. https://doi.org/10.1212/WNL.0b013e31828726ccCrossRefPubMed

16.

Droby A, Fleischer V, Carnini M et al (2015) The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients. Neuroimage Clin 8:110–116. https://doi.org/10.1016/j.nicl.2015.03.003CrossRefPubMedPubMedCentral

17.

Valk J, van der Knaap MS (1989) Wallerian degeneration and demyelination secondary to neuronal and axonal degeneration. Magnetic resonance of myelin, myelination, and myelin disorders. Springer, Berlin, pp 319–326CrossRef

18.

Filippi M, Rocca MA (2005) MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 252:v16–v24. https://doi.org/10.1007/s00415-005-5004-5CrossRefPubMed

19.

Dziedzic T, Metz I, Dallenga T et al (2010) Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol 20:976–985. https://doi.org/10.1111/j.1750-3639.2010.00401.xCrossRefPubMedPubMedCentral

20.

Singh S, Dallenga T, Winkler A et al (2017) Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis. J Neuroinflamm 14:1–15. https://doi.org/10.1186/s12974-017-0831-8CrossRef

21.

Vaithianathar L, Tench CR, Morgan PS et al (2002) T1 relaxation time mapping of white matter tracts in multiple sclerosis defined by diffusion tensor imaging. J Neurol 249:1272–1278. https://doi.org/10.1007/s00415-002-0836-8CrossRefPubMed

22.

Marques JP, Kober T, Krueger G et al (2010) MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage 49:1271–1281. https://doi.org/10.1016/j.neuroimage.2009.10.002CrossRefPubMed

23.

Mussard E, Hilbert T, Forman C et al (2020) Accelerated MP2RAGE imaging using Cartesian phyllotaxis readout and compressed sensing reconstruction. Magn Reson Med 84:1881–1894. https://doi.org/10.1002/mrm.28244CrossRefPubMed

24.

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis : an expanded disability status scale (EDSS). Neurology 33(11):1444–1453. https://doi.org/10.1212/wnl.33.11.1444CrossRefPubMed

25.

Fartaria MJ, Roche A, Meuli R et al (2017) Segmentation of cortical and subcortical multiple sclerosis lesions based on constrained partial. MICCAI LCNS 10435:516–524. https://doi.org/10.1007/978-3-319-66179-7CrossRef

26.

Fartaria MJ, Bonnier G, Roche A et al (2016) Automated detection of white matter and cortical lesions in early stages of multiple sclerosis. J Magn Reson Imaging 43:1445–1454. https://doi.org/10.1002/jmri.25095CrossRefPubMed

27.

Klein S, Staring M, Murphy K et al (2010) elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29:196–205. https://doi.org/10.1109/TMI.2009.2035616CrossRefPubMed

28.

Schmitter D, Roche A, Maréchal B et al (2015) An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer’s disease. Neuroimage Clin 7:7–17. https://doi.org/10.1016/j.nicl.2014.11.001CrossRefPubMed

29.

Piredda GF, Hilbert T, Granziera C et al (2020) Quantitative brain relaxation atlases for personalized detection and characterization of brain pathology. Magn Reson Med 83:337–351. https://doi.org/10.1002/mrm.27927CrossRefPubMed

30.

Avants BB, Tustison NJ, Song G et al (2011) A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 54:2033–2044. https://doi.org/10.1016/j.neuroimage.2010.09.025CrossRefPubMed

31.

Yeh FC, Panesar S, Fernandes D et al (2018) Population-averaged atlas of the macroscale human structural connectome and its network topology. Neuroimage 178:57–68. https://doi.org/10.1016/j.neuroimage.2018.05.027CrossRefPubMed

32.

RStudio Team (2020) RStudio: integrated development for R. RStudio Inc., Boston

33.

Piredda GF, Radojewski P, Bonanno G et al (2022) High-resolution T1 atlas for subject-specific abnormality detection at 7T. In: Proc Int Soc Magn Reson Med London, UK Abstract: 1268. https://doi.org/10.1002/mrm.29540

34.

Minneboo A, Barkhof F, Polman CH et al (2004) Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 61:217–221. https://doi.org/10.1001/archneur.61.2.217CrossRefPubMed

35.

Simon JH, Kinkel RP, Jacobs L et al (2000) A Wallerian degeneration pattern in patients at risk for MS. Neurology 54:1155–1160. https://doi.org/10.1212/WNL.54.5.1155CrossRefPubMed

Titel: Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis
verfasst von: Veronica Ravano
Gian Franco Piredda
Jan Krasensky
Michaela Andelova
Tomas Uher
Barbora Srpova
Eva Kubala Havrdova
Karolina Vodehnalova
Dana Horakova
Petra Nytrova
Jonathan A. Disselhorst
Tom Hilbert
Bénédicte Maréchal
Jean-Philippe Thiran
Tobias Kober
Jonas Richiardi
Manuela Vaneckova
Publikationsdatum: 11.10.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 2/2024
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-023-12023-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Supplementary Information

Introduction

Methods

Participants

Preprocessing

T1 normative atlas

Atlas-based white matter tract maps

Extraction of tract-specific z-scores

Statistical analysis

Results

General observations

Early MS cohort

Progressive MS cohort

Discussion

Declarations

Conflicts of interest

Ethical approval

Consent to participate

Consent to publish

Unsere Produktempfehlungen

e.Med Interdisziplinär

Neuer Inhalt

e.Med Neurologie & Psychiatrie

e.Med Neurologie

Supplementary Information

Weitere Artikel der Ausgabe 2/2024

Clinical outcome after thrombectomy in patients with MeVO stroke: importance of clinical and technical factors

Effects of pupil size in video head-impulse tests

Associations of C-reactive protein with depressive symptoms over time after mild to moderate ischemic stroke in the PROSCIS-B cohort

Gray matter loss relates to dual task gait in Lewy body disorders and aging

Serum sickness in a multiple sclerosis patient treated with ocrelizumab

Multiple sclerosis in the elderly: a retrospective cohort study

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

Schutz der Synapsen bei Alzheimer

Sozialer Aufstieg verringert Demenzgefahr

Update Neurologie